Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

Genes Chromosomes and Cancer

Volumn 18, Issue 2, 1997, Pages 84-93

  Calasanz, María J ^a   Cigudosa, Juan C ^a   Odero, María D ^a   Ferreira, Carmen ^a   Teresa Ardanaz, N ^e   Fraile, Ayrora ^d   Carrasco, José L ^b   Solé, Françesc ^f   Cuesta, Braulia ^c   Gullón, Arturo ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c Clinica Universitaria   (Spain)

^d Hospital Nuestra Senora de Aranzazu   (Spain)

^e HOSPITAL TXAGORRITXU   (Spain)

^f Hospital Central L'Alianca   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 14Q; CHROMOSOME 16Q; CHROMOSOME 22Q; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CYTOGENETICS; HUMAN; HUMAN CELL; KARYOTYPING; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PARAPROTEINEMIA; PLASMA CELL LEUKEMIA; PLOIDY; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOME FRAGILITY; HUMANS; KARYOTYPING; LEUKEMIA, PLASMACYTIC; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED; WALDENSTROM MACROGLOBULINEMIA;

EID: 0031035918     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X     Document Type: Article

References (23)

1. Ankatil R, Madhavan J, Gangadharan VP Pillai GR, Nair MK (1995) Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer Genet Cytogenet 83:71-74.
2. Belge G, Thode B, Rippe V, Bartnizke S, Bullerdiek K (1994) A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94;198-202.
3. Cigudosa JC, Calsanz MJ, Odero MD, Prosper F, Etxaniz A, Marin J, Rifon J, Gullon A, Rocha F. (1994) Cytogenetic data in 41 patients with multiple myeloma, Karyotype and other clinical Parameters, Cancer Genet Cytogenet 78;210-213.
4. Dewald GW, Kye RA, Hicks GA, Greipp PR (1985) The clinical significance uf cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66:380-390.
5. Drach J, Sheuster J, Nowntny H, Angerler J, Rosenthal F, Fielg M, Rothermundt C, Gsur A, Jäger U, Heinz R, Lechner K, Ludwig H, Huber H (1995a) Multiple myeloma: High incidence of chromosomal aneuploidy as defected by ibterphase fluorescence in situ hybridization, Cancer Res 55:3954.
6. Drach J, Angerler J, Sheuster J, Rothermudt C, Thalhammer R, Haas OA, Jäger U, Fielg M, Geissler K, Ludwig H, Huberr H (1995) Interphasc fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gaminapathy of' undetermined significance. Blood 86:3915-3921.
7. Durie BGM, Salmon SK (1475) A clinical staging system for multiple myeloma. Cancer 36:842-854.
8. Facon T, Laï, JL, Nataf E, Preudhomme C, Zandecki M, M. Hammad M, Wattel E, Jouet JP, Bauters F (1993) Improved eytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients, Br J Haematol 84:743-745.
9. García-Sanz R, Orfao A, González M, Moro Hernã JM, Ortega F, Borrego D, Carnero M, Casanova F, Jiménez R, Portero JA, San Miguel JF (1995) Prognostie implications of of DNA aneuploidy in 156 untreated multiple myeloma patients. Br J Haematol 90:106-112.
10. Guthensohn K, Weh HJ, Walter TA, Hossfeld DK (1992) Cytogenetics in multiple myeloma and plasma cell leukemia; Simultaneous cytogenetic and cytologic studies in 51 patients. Ann Hematol 65:88-90.
11. ISCN (1991): Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Mitelman F (ed). Basel: S Karger.
12. Karpas A, Fisher P, Swirsky D (1982) Human plasmacytoma cell line carrying a philadelphia chromosome. Science 216:997-999.
13. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczy KV, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497.
14. Lewis JP, Mackenzie MR (1984) Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol 2:307- 317.
15. Lisse IM, Drivsholm A, Christoffersen P (1988) Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: Correlation with survival. Cancer Genet Cytogenet 35:27-36
16. Sawyer JR, Waldrom JA, Jagannath S, Barlogie B (1995) Cytogenetic findings in 200 patients with multiple myeloma, Cancer Genet Cytogenet 82:41-49.
17. Smadja NV, Louvet C, Isnard F, Dutel J-L, Grange M-J, Varette C, Krulik M (1995) Cytogenetic study in multiple myelima at diagnosis: Comparison of two techniques. Br J Heamatol 90:619-624.
18. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, Kashima K(1994) Nonrandom chromosomal rearrangements of 14q32 and 19p13.3 and preferential deletion of 1 p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283-2290
19. Tricot G, Barlogie B, Jagannah S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities, Blood 86:4250-4256.
20. Van den Berghe H, Louwagie A, Broeckaert-Van, Orsoven A, David G, Werwilghen R, Michaus JL, Sokal G (1979) Philadelphia chromosome in human multiple myeloma. J Natl Cancer Inst 63:11-16
21. Van den Berghe H, Vermaelen K, Louwagie A, Criel A, Mecuci C, Vaerman JP (1984) High incidence of chromosomal abnormalities in lgG3 myeloma, Cancer Genet Cytogenet 11:381-387.
22. Weh HJ, Fiedler W, Hossfeld DK (1990) Cytogenetics in multiple myeloma. Are we studying the "right" Cell? Eur J Haematol 45:236-237
23. Weh HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhans G, Seeger D, Fiedler W, Fett W, Hossfeld DK (1993) Karyotype in multiple myeloma and plasma cell leukemia. Eur J Cancer 29A:1269-1273